GetTopicDetailResponse(id=70a789006e1, topicName=血塞通, introduction=血塞通, content=null, image=null, comments=3, allHits=1376, url=https://h5.medsci.cn/topic?id=89006, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=31922, tagList=[TagDto(tagId=31922, tagName=血塞通)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1604527, encodeId=8e3a160452ec7, content=<a href='/topic/show?id=70a789006e1' target=_blank style='color:#2F92EE;'>#血塞通#</a>, objectTitle=基藥目錄大調(diào)整，血塞通在基層不能用了？, objectType=article, longId=152141, objectId=7e22152141a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e22152141a8, replyNumber=0, likeNumber=76, createdTime=2018-10-30, rootId=0, userName=xiaoyang_ambs, userId=c28219213331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e22152141a8, moduleTitle=基藥目錄大調(diào)整，血塞通在基層不能用了？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7e22152141a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1604526, encodeId=938d160452610, content=<a href='/topic/show?id=70a789006e1' target=_blank style='color:#2F92EE;'>#血塞通#</a>, objectTitle=血栓通、血塞通被限！一批醫(yī)院不能用, objectType=article, longId=144844, objectId=b64514484400, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b64514484400, replyNumber=0, likeNumber=83, createdTime=2018-07-22, rootId=0, userName=xiaoyang_ambs, userId=c28219213331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b64514484400, moduleTitle=血栓通、血塞通被限！一批醫(yī)院不能用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b64514484400)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1604525, encodeId=220b1604525ac, content=<a href='/topic/show?id=70a789006e1' target=_blank style='color:#2F92EE;'>#血塞通#</a>, objectTitle=血塞通、血栓通有8大不良反應(yīng)，CFDA已發(fā)通告！, objectType=article, longId=62066, objectId=c12f62066c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c12f62066c1, replyNumber=0, likeNumber=95, createdTime=2016-01-15, rootId=0, userName=xiaoyang_ambs, userId=c28219213331, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c12f62066c1, moduleTitle=血塞通、血栓通有8大不良反應(yīng)，CFDA已發(fā)通告！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c12f62066c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
